EVH
Evolent Health, Inc. · Healthcare · Medical - Healthcare Information Services
Momentum inputs (comparable managers):
holder breadth +5.6% ·
share flow +12.0% ·
net new positions 0.0%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 78 | +6 | 70.64M | $382.54M | +11 | −4 |
| Q1 2026 | 73 | -12 | 65.20M | $148.81M | +7 | −20 |
| Q4 2025 | 86 | 0 | 77.77M | $307.90M | +1 | n/a |
| Q3 2025 | 19 | +1 | 60.10M | $508.46M | +2 | −2 |
| Q2 2025 | 16 | -1 | 36.98M | $416.34M | n/a | −1 |
| Q1 2025 | 14 | 0 | 22.70M | $214.97M | +1 | −1 |
| Q4 2024 | 14 | +1 | 27.38M | $247.73M | +1 | n/a |
| Q3 2024 | 12 | 0 | 21.00M | $593.78M | +1 | −1 |
| Q2 2024 | 12 | n/a | 19.79M | $378.42M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 10.97M | +0.4% | $92.78M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passive) | 9.31M | -0.7% | $78.80M | 0.0% | ▼ Trim | 2 | SEC ↗ ×16 |
| 3 | Fidelity (FMR) ✦ | 8.75M | +36.3% | $74.02M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 4 | JPMorgan Chase ✦ | 8.00M | n/a | $67.70M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 5 | Morgan Stanley ✦ | 7.98M | n/a | $67.50M | 0.0% | n/c | 1 | SEC ↗ ×15 |
| 6 | State Street Global Advisors ✦ (passive) | 2.97M | +0.1% | $25.16M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 7 | Geode Capital Management ✦ (passive) | 2.76M | +3.4% | $23.33M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | D. E. Shaw & Co. ✦ | 2.74M | +30.1% | $23.16M | 0.0% | ▲ Add | 4 | SEC ↗ ×4 |
| 9 | Citadel Advisors ✦ | 2.30M | +291.3% | $19.43M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Goldman Sachs Group ✦ | 881.34K | n/a | $7.46M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 11 | Two Sigma Investments ✦ | 851.14K | +133.8% | $7.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Marshall Wace ✦ | 654.75K | +2345.0% | $5.54M | 0.0% | ▲ Add | 6 | SEC ↗ ×3 |
| 13 | Point72 Asset Management ✦ | 601.98K | New | $5.09M | 0.0% | New | 1 | SEC ↗ |
| 14 | Millennium Management ✦ | 456.62K | -27.5% | $3.86M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 15 | Renaissance Technologies ✦ | 310.10K | New | $2.62M | 0.0% | New | 1 | SEC ↗ |
| 16 | GAMCO Investors ✦ | 244.00K | -0.5% | $2.06M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 17 | Adage Capital Partners ✦ | 188.52K | -34.7% | $1.59M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 115.76K | +9.4% | $980,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 18.50K | -10.7% | $156,517 | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $5.09M | 0.0% |
| Renaissance Technologies | $2.62M | 0.0% |
Exited
| Norges Bank | $2.02M | was 0.0% |
| Wellington Management | $729,986 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 7.50M shares, $3.77M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 65.89K sh · $329,460
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology